CV protection by SGLT2 inhibition: Potential mechanisms for benefit

3' education - May 10, 2016 - Kuala Lumpur, Malaysia - Prof Hiddo Lambers Heerspink, Groningen, The Netherlands

Disclosures

Prof. Hiddo Lambers Heerspink - Department of Clinical Pharmacology, University Medical Center Groningen, The Netherlands

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.